Appleton Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-907
| Closed | -$797K | – | 283 |
|
|
2023
Q4 | $797K | Hold |
907
| – | – | 0.06% | 152 |
|
|
2023
Q3 | $746K | Sell |
907
-3
| -0.3% | -$2.47K | 0.07% | 153 |
|
|
2023
Q2 | $654K | Hold |
910
| – | – | 0.06% | 174 |
|
|
2023
Q1 | $748K | Hold |
910
| – | – | 0.07% | 175 |
|
|
2022
Q4 | $657K | Hold |
910
| – | – | 0.06% | 179 |
|
|
2022
Q3 | $627K | Hold |
910
| – | – | 0.06% | 183 |
|
|
2022
Q2 | $538K | Sell |
910
-8
| -0.9% | -$4.73K | 0.05% | 194 |
|
|
2022
Q1 | $641K | Sell |
918
-3
| -0.3% | -$2.1K | 0.05% | 190 |
|
|
2021
Q4 | $582K | Buy |
+921
| New | +$582K | 0.04% | 208 |
|